ExpiresOctober 1, 2022
CME Provider: Louisiana Medical Mutual Insurance Company (LAMMICO)
Description of CME Course
While concerns about the opioid epidemic are paramount, many other controlled substances are being misused and abused. This course describes the best practices and special considerations necessary for prescribing any controlled dangerous substance. Medication reconciliation and the dangers of polypharmacy, especially among the elderly are emphasized. Issues surrounding prescribing for pain, focusing on chronic pain along with risk assessment for addiction, discussion of alternative therapies, medication treatment agreements, tapering and discontinuation, and consistent use of risk and pain assessment tools are included. Addiction treatment topics including the basic neurobiology behind addiction, the stages of treatment, and the different kinds of rehabilitation programs and modalities offered to assist in the recovery process are also discussed. This course meets the requirements for 3 hours of education on Opioid and controlled substance prescribing and treatment for Arkansas prescribers who have been newly licensed within the past two years.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Allergy and Immunology
Colon and Rectal Surgery
Medical Genetics and Genomics
Physical Medicine and Rehabilitation
Psychiatry and Neurology
NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Prescribers of controlled dangerous substances will employ best practices when prescribing. These include:
Perform a complete patient assessment before prescribing controlled substances, including physical, mental and psychosocial status.
Utilize multimodal treatment options instead of or in addition to pharmacological strategies, especially when treating for pain.
Discuss the Centers for Disease Control and Prevention's (CDC's) guidelines for opioid prescribing for chronic pain.
Identify key elements to be documented in patient records when prescribing controlled dangerous substances.
Utilize person-first language in discussions related to addiction treatment and recovery.
Explain the phases of treatment for patients with substance use disorders.
Compare the risks and benefits of the common medications used in medication assisted treatment and recovery.
Discuss the Arkansas laws and rules regarding chronic pain management, the prescription Drug Monitoring Program, and combating abuse.
Controlled Substances, Arkansas Medical license, Prescribing
Professionalism, Systems-based Practice
CME Credit Type
AMA PRA Category 1 Credit
Academic Medicine, Inpatient, Outpatient, Rural, Urban, VA/Military